Cannabis Bioscience International Holdings, Inc. (CBIH) Return on Sales (2022 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Return on Sales of 0.09% for Q1 2026, down 334.83% sequentially from 0.02% in Q4 2025, and up 1.0% YoY from 0.09% in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Return on Sales (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Return on Sales for 5 years, with the latest figure at 0.09% in Q1 2026.
- Quarterly Return on Sales rose 1.0% year-over-year to 0.09% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 0.06% (down 5.0% YoY) and the FY2025 annual result came in at 0.02%, up 1.0% from the prior year.
- Return on Sales eased to 0.09% in Q1 2026 per CBIH's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q3 2024 and troughed at 0.1% in Q1 2025.
- A 5-year average of 0.05% and a median of 0.04% in 2024 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales climbed 5 bps in 2024, then declined 8 bps in 2025.
- Over 5 years, Return on Sales stood at 0.03% in 2022, then increased by 27 bps to 0.02% in 2023, then soared by 53 bps to 0.01% in 2024, then sank by 132 bps to 0.02% in 2025, then plunged by 335 bps to 0.09% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.09%, 0.02%, and 0.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.09% |
| Nov 30, 2025 | -0.02% |
| Aug 31, 2025 | -0.09% |
| May 31, 2025 | -0.08% |
| Feb 28, 2025 | -0.10% |
| Nov 30, 2024 | -0.01% |
| Aug 31, 2024 | -0.01% |
| May 31, 2024 | -0.01% |
| Feb 29, 2024 | -0.06% |
| Nov 30, 2023 | -0.02% |
| Aug 31, 2023 | -0.02% |
| May 31, 2023 | -0.06% |
| Feb 28, 2023 | -0.06% |
| Nov 30, 2022 | -0.03% |